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An increasing proportion of older adults with Alzheimer’s disease or other dementias are now surviving to more advanced stages
of the illness. Advanced dementia is associated with feeding problems, including diﬃculty in swallowing and respiratory diseases.
Patients become incompetent to make decisions. As a result, complex situations may arise in which physicians and families decide
whether artiﬁcial nutrition and hydration (ANH) is likely to be beneﬁcial for the patient. The objective of this paper is to present
methods for evaluating the nutritional status of patients with severe dementia as well as measures for the treatment of nutritional
disorders, the use of vitamin and mineral supplementation, and indications for ANH and pharmacological therapy.
1.Introduction
Dementia is one of the most common and most signiﬁcant
health problems in the elderly and is one of the main causes
of disability in older age [1] A growing proportion of older
adults with Alzheimer disease (AD) or other dementias are
now surviving to more advanced stages of the illness [2, 3].
Much clinical attention and research eﬀort has been
directedtowardsearlydiagnosisandmildstagesofdementia,
and prodromal stages, formerly classiﬁed as mild cognitive
impairment (MCI). The later stages of the disease are as
important as, if not more important than, the earlier stages
because of the unique characteristics and events which
occur aﬀecting the lives of patients and their carers. Severe
dementia (SD) is still relatively neglected and its prevalence
is unclear, but it is estimated that one-third of dementia
patients are in the severe stages [4–6].
There are several causes for concern in SD, when many
impairments become more apparent: functional disabilities
mean that carers have to take over more practical tasks,
such as bathing, toileting, and feeding; there are special
considerations with palliative care and ethical issues of
terminal care along with physical problems [7–9].
SD, including AD, is associated with feeding problems,
including diﬃculty in swallowing, leading to choking,
chewing but failing to swallow, and active resistance to
hand feeding. Because patients with dementia have limited
language and communication abilities, it is diﬃcult to
identify the source of aversive behavior [9, 10]. Nevertheless
eating and drinking may well be a sensory pleasure for
people with SD. That potential source of pleasure should
be maximized while at the same time ensuring optimum
nutrition and hydration [11].
In addition, weight loss is a frequent complication of
AD and occurs in patients at all stages, even in the early
stages before diagnosis is possible. Malnutrition (namely,
undernutrition) contributes to the alteration of general
health status, to the frequency and gravity of complications,
especially infections, and to a faster loss of independence.
These states of malnutrition can be prevented or at least
improved if an early intervention strategy is set up, but
management must be rapid and appropriate. Weight loss is
a phenomenon whose kinetics may vary; it can be a dramatic
loss of several kilograms in a few months (severe weight loss)
or a moderate but continuous loss as the disease progresses
(progressive weight loss) [12, 13].
With progressive dementia, patients become incompe-
tent to make decisions. As a result, complex situations
may arise in which physicians and families decide whether
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beneﬁcial for the patient [14–16]. Many people with SD will
ultimately experience dysphagia, which in turn is associated
with aspiration pneumonia. Decisions about how to respond
when someone develops swallowing problems are discussed
elsewhere in this paper [17].
Artiﬁcial nutrition is the provision of liquid nutritional
supplement by the enteral or parenteral route. The decision
whether or not to provide artiﬁcial nutrition often evokes a
powerful emotional response. Because surrogates and other
loved ones agonize over the withholding and/or withdrawal
of artiﬁcial nutrition, healthcare providers need to be
ready to discuss the most current data regarding eﬃcacy,
complications, and the ethical and legal issues [18–20].
2. Deﬁnition of Severe Dementia
SD can be deﬁned as the stage of the disease process of
dementia in which cognitive deﬁcits are of suﬃcient mag-
nitude as to impair an otherwise healthy person’s ability to
independently perform the basic activities of daily life, such
as dressing, bathing, and toileting. Deﬁnitions of SD vary
from those which use a speciﬁc cutoﬀ on a cognitive scale
such as the Mini Mental State Examination. In accordance
with the literature, we deﬁned SD as follows [4]:
(i) score of less than 10 in the Mini Mental State
Examination (MMSE) [21]o r
(ii) score of 3 or higher in the Clinical Dementia Rating
(CDR) [22], or
(iii) categories 6a to 7f in the Functional Assessment
Staging Test (FAST) [23], or
(iv) score of 6 or 7 on the Global Deterioration Scale
(GDS) [24].
Some investigators state that the incorporation of these
instruments into clinical trials has allowed the rate of
worsening or improvement of patients to be quantiﬁed
in advanced stages. Moreover, they have permitted better
stratiﬁcation of this long stage known as SD, which includes
patients with very diﬀerent cognitive, behavioral, and func-
tional proﬁles. Thus, among patients classiﬁed as CDR 3,
known as SD, there are individuals who still communicate
verbally and walk without support, but also others who are
conﬁned to bed, unable to lift their heads, or already in
the fetal position. The advantages of better classiﬁcation of
advanced dementia include the possibility of better studies
designed to validate interventions in cognition, behavioral,
andfunctionalstatus,aswellasbetterapproachesinterminal
dementia using palliative care [5, 25].
Although by deﬁnition the functional impairment in
dementia must be related to the cognitive decline, there are a
number of other factors such as parkinsonism and comorbid
disorders that by themselves contribute signiﬁcantly to the
functional disability [26].
So, unlike the dying trajectory in more-acute illnesses,
patients with dementia have a long period of severe func-
tional and cognitive impairment before death [27].
3. NutritionalEvaluationof Patientswith
AdvancedDementia
Cachexia and weight loss are common signs among AD
patients. These ﬁndings have been studied to see if there is
any correlation between organic deﬁciency caused by low-
energy intake and the acute state of hypercatabolism these
patients present. Undernourishment has been suggested to
be a factor in the etiology of dementia and other psychiatric,
and cognitive disorders, although nothing has been proven
in this respect [28, 29].
Weight loss in AD may be correlated to the presence
of higher rates of infection, the burning of energy due to
repetitivemovementsandcognitivedeﬁcitthatcompromises
the patient’s independence [30, 31].
This process increases the risk of infections, skin ulcers
and stimulates loss of body temperature, whichconsequently
compromises the quality of life of patients with AD [32].
There is a theory behind the weight loss seen in AD
patients that is based on the morphology and that has to do
with the brain lesions caused by the disease, and a signiﬁcant
association has been found between low body weight and
atrophy of the mesial temporal cortex in the region of the
central nervous system responsible for eating behavior [33].
Gu´ erin et al. [12]o b s e r v e dt w of o r m so fw e i g h tl o s s ,
one slow and progressive, the other rapid and severe. A
severe weight loss was related to the seriousness of the
disease, the higher number of hospital admissions, clinical
events, and institutionalization, which led the researchers to
conclude that these patients might beneﬁt from nutritional
interventions.
Mun˜ oz et al. [34] found that there is impairment of the
energyandmusclereservesatallstagesofthedisease,butthat
there is a greater impairment of the Body Mass Index (BMI),
and brachial fatty and lean mass, in the advanced stage.
Given these ﬁndings, evaluation of their nutritional
status is crucially important for these patients. The result of
the nutritional evaluation will guide the management to be
followed in each case.
The nutritional evaluation of these patients may be
carried out using a number of traditional methods based
on objective evaluations such as anthropometry, the eval-
uation of clinical signs that are indicative of malnutrition,
evaluation of food intake, the subjective Mini Nutritional
Assessment (MNA), and by NSI-Nutrition Screening Initia-
tive [35].
The MNA was developed in order to assess the risk of
malnutrition in the elderly and identify those who could
beneﬁt from early intervention. This evaluation is made of
18 items including: anthropometry, nutritional evaluation,
global clinical evaluation and self-perception of health, and
maybeusedbothinscreeningandtoevaluatethenutritional
status; any trained health professional can apply it [36].
The NSI is a self-applied questionnaire made up of 10
questions, created in order to assess primary health care;
however, its use is not widely recommended since it has
shown limited power of prediction for mortality in the
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Most authors, despite these methods, consider the use of
anthropometrical measurements to be the gold standard for
nutritional evaluation, along with outpatient tests for total
lymphocytes, albumin, blood cholesterol, hemoglobin, and
transferrin [38].
A nutritional evaluation study made in a long-stay insti-
tution with dementia syndrome, depression, and cardiovas-
cular diseases, using anthropometric data gathering, found
that36.6%ofthesepatientsweremalnourished,demonstrat-
ing the importance of early nutritional intervention [39].
Spaccavento et al. [13], using MNA to investigate the
role of the nutritional status, correlating it to cognitive,
functional, and neuropsychiatric deﬁcits in AD patients,
found that patients at risk of malnutrition showed greater
impairment, both in simple instrumental daily life activities
(DLA and IDLA) and a greater likelihood of presenting hal-
lucinations, apathy, aberrant and nocturnal motor behavior
on the sub-scales of the Neuropsychiatric Index (NPI).
Weight loss has a negative impact on the prognosis of AD
sincethemoreseverethemalnutritionisthefasterwillbethe
clinical progression leading to the death of patients [40].
4. NutritionalManagement of Patients with
AdvancedDementia
4.1. Does Oral Nutritional Therapy (ONT) in Patients with
Advanced Dementia Bring Beneﬁt for the Nutritional Status?
In patients with advanced dementia there is a reduced capac-
ity for communication, loss of pleasure in eating, changes
in mastication leading to diﬃculty in swallowing certain
consistencies of food, and culminating in dysphagia [41].
These patients tend to present reduced mobility leading
to loss of muscle mass even when not malnourished. In
these cases nutritional therapy plays an essential role since
it aims to provide comfort in the eating process and assure
the patient’s dignity [31].
As AD advances, the diﬃculty of keeping these patients’
weight up through conventional feeding increases, and in
these cases it is recommended to use high-calorie concen-
trates [42].
ESPEN, the European Society for Clinical Nutrition and
Metabolism [43], classiﬁes as evidence level C the use of
dietary supplements to maintain the nutritional status of
patients with dementia.
Pivi et al. [44], in their study of oral nutritional therapy
with patients at diﬀerent stages of AD, found that an
additional 690kcal/day in these patients’ diets led to an
improvement of the nutritional indices BMI, BC (brachial
circumference), BMC (brachial muscle circumference), and
TLC (total lymphocyte count), demonstrating that nutri-
tional supplementation is in fact eﬀective at any stage of the
disease.
Carver and Dobson [45] likewise found that dietary sup-
plementation signiﬁcantly increases body weight, tricipital
skin fold, and brachial muscle circumference in hospitalized
elderly dementia patients.
Although dietary supplementation shows beneﬁts for
nutritional status, only 11% of outpatients use them, as
as t u d yb yT r e l i sa n dL ´ opez [46] showed. This study
highlighted the importance of the entire team involved in
the treatment of dementia patients being able to perceive the
onset of nutritional deﬁcit and so refer the patient to the
nutritionist to indicate the best type of supplement for each
case.
Other studies with nondemented elderly patients with
other clinical needs also showed the eﬀectiveness of using
dietary supplements in addition to the habitual diet. Volkert
et al. [47] showed that elderly patients over 75 who were
given caloriﬁc supplementation of 500kcal/day improved
their convalescence and recovery from deﬁciency states.
It is important to mention that there are lines of research
that recommend the prescription of dietary supplements
only for patients with low BMIs, since they may abandon
their habitual diets in favor of dietary supplements [48].
Young et al. [49] also demonstrated this concern in a
study with use of dietary supplements for 21 days in ad-
dition to their habitual diets. Those patients who received
nutritional supplements were observed to have less likeli-
hood of increasing energy intake in their habitual diets.
The researchers stressed out that patients with low body
weight have a greater chance of beneﬁtting from the use of
nutritional supplements.
This whole discussion leads us to observe that a natural
dietingestedbymouthpromotespatientcomfortanddignity
and may not shorten survival, since there are reports of
patients who survived two years exclusively feeding by
mouth [31]. There is evidence that dietary supplementation
may enhance the nutritional status of dementia patients,
regardless of the phase at which they are. The signiﬁcance
of this nutritional improvement has yet to be determined for
the rate of cognitive and functional decline.
5. Use of VitaminsandMineralsin
Alzheimer’s Patients
No speciﬁc or deﬁnitive environmental risk factor has been
identiﬁed as the likely cause of AD, but there are research
lines that correlate diet as a preventive and improving factor
for the dementia states.
There is evidence of worsening of the cognitive condition
linked to the increase of homocysteine, whereas the con-
sumption of fats and red grapes seems to have a protective
eﬀect for AD patients [50].
De Jong et al. [51] studied patients who followed dietary
instructions and consumed foods supplemented daily with
0.25mg of folic acid and 2.5mg B6 vitamin; they found
that these participants showed a reduction in the serum
concentration of homocysteine of around 25%. This result
suggests that a low concentration of homocysteine may
inhibit the development of dementia.
Morris et al. [52] studied nurses who consumed polyun-
saturated fatty acids at least once a week; although results
were not conclusive, they suggested that this cohort had a
lower risk of developing AD.
Polyphenols, in particular resveratrol, found in great
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of AD owing to their antioxidant properties, although this
has not yet been proved [53, 54].
A study of supplementation with low concentration of
folic acid and B vitamin complex were made to investigate
the association of these substances with enhanced cognitive
function.Itraisedtheprospectofreductionofdementiarisk,
but researchers emphasized that more studies are needed to
prove this [55].
Study with AD patients in the mild phase who received
micronutrient supplementation for six months found that,
when compared to the control group, there was no beneﬁt
in the supplementation for the evolution of the disease, the
nutritional status, the biochemical parameters, the cognitive
function, and the behavior and eating disorders that these
patients commonly present [56].
Despite the evidences, caution must be taken in adopting
such approaches, since more studies on micronutrient
supplementation need to be performed in order to observe
real beneﬁts for dementia.
6.IndicationofArtiﬁcialNutritionand
Hydrationin Advanced Dementia Patients
The use of Enteral Nutrition Therapy (ENT) or Artiﬁcial
Nutrition and Hydration (ANH) is only indicated when
there is a risk of malnutrition and severe impairment of
the swallowing process, with the possible consequence of
aspiration pneumonia [57].
According to ASPEN—American Society for Parenteral
and Enteral Nutrition [58], an ENT in patients with
advanced dementia is classiﬁed as category E, not obligatory
in those cases. The decision for ENT must be based
on eﬀective communication with the caregivers to decide
whether it should be used or not.
The use of nasogastric or nasoenteric tubes in patients
with dementia is not recommended as they may pull out the
tube, leading to discomfort for patient and family both, since
the patient will have to be reintubated [59]. Gastrostomy is
normally indicated as the route for alternative feeding, since
it is already commonplace and laid down in rules when the
duration of ENT is over six weeks [60].
ANH using feeding tubes or gastrostomy has been
routinely indicated for patients in advanced stage of demen-
tia who present serious problems swallowing, in order to
prevent malnutrition, hydrate the patient properly, and
provide comfort. Some studies, however, have put forward
issues for the nonuse of ANH in these patients [59].
See Table 1 setting out the major studies in this ﬁeld
and their recommendations regarding ANH in advanced
dementia patients:
The use of ANH in patients with dementia is very
controversial being necessary identiﬁcation of the goals for
an intelligent and rational judgment [65].
Deciding whether to use ANH in dementia patients is
a challenge and many caregivers may take their decisions
without adequate information and based on an over-
optimistic view of the future clinical course of this patient.
Health professionals, relatives, and patients should be aware
of the realistic expectations of tube feeding and of its risks
and beneﬁts before taking such a decision [18].
Ethical dilemmas are related to ANH and it is useful
in cases of severe dementia, being necessary to make valid
clinical judgments and to guide patients and their families
to exchange options related to initiating, withholding, or
withdrawing ANH. All this process should be comprehensive
andunderstoodfromtheorytopractice.Theuseofinformed
consent for competent caregivers is important in those cases
[66].
7. Pharmacologic Therapies
Several randomized controlled trials have been published on
atypical antipsychotic therapy for behavioral and psycholog-
ical symptoms in patients with SD.
Some results suggested no signiﬁcant diﬀerence between
any of the treatments compared with placebo. They also
support the recommendation for the use of atypical antipsy-
chotics only in the presence of severe agitation, aggression,
or psychosis that places the patient or those in their
environment at risk. Other psychotropic drugs include the
antidepressantsandanticonvulsants.Onbalance,theeﬃcacy
of the atypical antipsychotics appears to be superior to
that of other classes of drugs despite the increased risks.
However, there are few, if any, head-to-head comparisons
to truly characterize all risks and beneﬁts [7]. In a meta-
analysisadverseeventsofatypicalantipsychoticsweremainly
somnolence and urinary tract infection or incontinence
across drugs, and extrapyramidal symptoms or abnormal
gait were observed with risperidone or olanzapine. There
was no evidence for increased injury, falls, or syncope.
But there was a signiﬁcant risk for cerebrovascular events,
especially with risperidone [67]. With all these studies it is
possibletoimaginethatmanagementofbehavioraldisorders
could improve nutritional status. We also know that some
antipsychotic drugs could improve appetite, and we could
use these drugs to improve food intake. But more studies are
needed to better assess clinical signiﬁcance and eﬀectiveness
of these hypotheses.
Pharmacological therapies for the improvement of cog-
nition include cholinesterase inhibitors and memantine,
suggesting that this class of medication improves cognition,
function,behavior,andglobalmeasures.Thereisaconsensus
to recommend their use in patients with severe Alzheimer’s
disease.
The most common side eﬀects are gastrointestinal and
include anorexia, nausea, vomiting, and diarrhea [7]. It is
therefore very important to pay attention to these problems
so as not to impair food intake. There are no studies in the
literature to demonstrate whether cholinesterase inhibitors
or memantine could improve the nutritional status.
It is also important to register that there are no well-
designed randomized studies to demonstrate beneﬁts of
appetite stimulant drugs. We know that it is common
medicalpractice,butevidenceofthemechanisms,safety,and
eﬃcacy is lacking.Current Gerontology and Geriatrics Research 5
Table 1: Results of the main studies in artiﬁcial nutrition and hydration (ANH) in patients with severe dementia.
Study Objective and methodology Results Conclusion
Ciocon et al. [61]
Evaluate the indications, beneﬁts,
and complications of ANH in
patients using enteral tube, with
serious swallowing disorders and
at risk of aspiration
67% of patients were agitated
when the tube was removed and
43% had aspiration pneumonia
during the study
Researchers concluded that the
use of ANH may lead to a high
frequency of complications
Finucane et al. [10]
Review of the literature (1966 to
1999) to evaluate the use of ANH
in advanced dementia
No data to suggest that the use of
ANH may prevent aspiration
pneumonia, reduce the risk of
infections or prolong life
Most studies show that there are
substantial risks in using ANH in
these patients, and thus its use is
discouraged
Li [62] Review the use of ANH in
patients with advanced dementia
ANH does not prevent
malnutrition, reduce the
occurrence of bed sores, or
prevent aspiration pneumonia,
nor does it prolong life
Although it may not be eﬀective
in preventing malnutrition and
dehydration, this type of feeding
allows a degree of maintenance
and patient comfort
Pasman et al. [19]
Evaluate the discomfort of
patients with serious dementia of
a Dutch nursing home
The highest rates of discomfort
observed in these patients were
in dyspnea, acute pain, and
agitation
Not choosing ANH did not
correlate with the level of
discomfort of the patients. ANH
was identiﬁed as an individual
decision
Clarﬁeld et al. [63]
Evaluate the use of ANH in
patients with advanced dementia
admitted to Israeli and Canadian
hospitals in order to ﬁnd the
main diﬀerences between
ethnicities and ethical issues
24,5% patients were in if fed by
ANH
These results may be explained
by a combination of
administrative or ﬁnancial
incentives and by religion and
culture
Volkert et al. [43]
ESPEN Guideline developed to
recommend use of ONT or ANH
in elderly patients based on
scientiﬁc evidence
No increase in survival associated
with this use, leading the
researchers to consider ANH
only according to patient’s or
family’s wishes
ANH not recommended in
patients with advanced dementia
Buiting et al. [64]
To investigate the opinion of
Dutch and Australian physicians
on use of ANH in patients with
advanced dementia
Dutch physicians based their
decision on a wide-ranging
evaluation, while Australian
physicians tended to use
scientiﬁc evidence
All are reluctant at beginning of
ANH but Dutch physicians tend
to take primary responsibility for
the decision, while Australian
physicians prefer to leave the
decision to the family
8. FinalRemarks
There have been studies to develop drugs and treatments to
understand nonpharmacological measures, to ﬁnd epidemi-
ological factors that aﬀect the natural history of this disease,
but they are not conclusive to deﬁne ways to approach the
e n do fl i f eo rt ol o o ki n t oi s s u e ss u c ha ss u i t a b l en u t r i t i o n
for these patients. The long drawn-out course and uncertain
time frame of the prognosis raise considerable doubts as
to decisions to be taken by the team of carers and by the
relatives.
This paper demonstrates the palliative care that should
be given in order to improve the patient’s quality of life. All
aspects of the treatment of these patients should therefore be
part of the responsibilities of the multiprofessional team. It
should act cohesively to help relatives take the best decisions
in choosing treatment for their loved ones.
This view of comfort and of the right proportions
between actions taken and the principle of nonharm may
serve as a guide in decision making, especially as regards
nutrition issues [8].
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